5.2. Analysis.

Comparison 5: Denosumab versus placebo for patients with osteoporosis and CKD stages 3‐4, Outcome 2: Clinical fracture

Comparison 5: Denosumab versus placebo for patients with osteoporosis and CKD stages 3‐4, Outcome 2: Clinical fracture